Skip to content
Research Article Open access CC BY 4.0

Achieving the 6th MDG: An Evaluation Drug Treatment of Malaria in Selected PHC in Osun State

O. L. Abodunrin, A. O. Sabageh, A. O. Adeoye, A. A. Adeomi, J. O. Bamidele, F. F. Osundina

International Journal of TROPICAL DISEASE & Health · pp. 84–90 · Published 5 Nov 2014

10.9734/IJTDH/2015/11932

Abstract

Introduction: The burden of malaria in Nigeria and Africa is well documented. The current Nigeria anti-malaria drug policy has recommended artemisinin-based combination therapy (ACT) as the first-line drug treatment for uncomplicated malaria since 2005. It is now 8 years since the adoption of ACT and two years to the set time for the achievement of the MDGs. Objective: To assess the adherence of the PHC to the new policy on drug treatment for uncomplicated malaria. Methods: Using a pro-forma, relevant information about drug prescription of malaria cases between January 2008 and December 2009 was extracted from patients’ folders in the 3 comprehensive health centres being used by LAUTECH Teaching Hospital, Osogbo. Additional data were also collected through the use of in-depth interviews. Data were analyzed with Epi-Info software 3.4.2. Results: A total of 8881 episodes of malaria were analyzed of which male children (0-5years) constituted the highest number. The commonest prescribed anti-malaria was oral Chloroquine (21.6%) for the 3 CHC combined. However, for each CHC, CQ was the commonest drug prescribed for Ilie and Atelewo CHC (41.6% and 25.5% respectively), while for Akogun CHC alone, it was Artesunate + SP. Akogun CHC was found to have the highest prescribed pre-packaged ACT. Factors responsible for inappropriate prescription were non-availability and perceived patients' non-affordability and unwillingness to buy drugs. Conclusion: Prescription of CQ and SP as mono-therapy continues to prevail in the CHC. There is urgent need for ensuring compliance to the current and acceptable treatment for malaria. Other means of sustaining availability of anti-malaria drugs should be considered.

Evaluation prescription anti-malaria MDG PHC drug treatment ACT

References (7)

  1. 1 The economic and social burden of malaria [DOI]
  2. 2 Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria [DOI]
  3. 3 Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria [DOI]
  4. 4 Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study [DOI]
  5. 5 Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009 [DOI]
  6. 6 Costs and financing of improvements in the quality of maternal health services through the Bamako Initiative in Nigeria [DOI]
  7. 7 Malaria endemicity among pregnant women in urban and semi-urban areas in Southwest, Nigeria.

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

29

Page views

0

PDF downloads

3

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.